Seattle, WA, United States of America

Oncothyreon Inc.


USPTO Granted Patents = 10



Forward Citations = 58

Loading Chart...
Loading Chart...

15 inventors (with patents filed for the assignee):

goldMedal B Michael Longenecker (5 out of 14 patents)

silverMedal Wladyslaw A Budzynski (4 out of 4 patents)

bronzeMedal R Rao Koganty (4 out of 7 patents)

4 Scott Peterson (2 out of 5 patents)

5 Linda Pestano (2 out of 2 patents)

6 Diana F Hausman (2 out of 4 patents)

7 Jeffrey Millard (2 out of 2 patents)

8 Sandy Koppenol (2 out of 3 patents)

9 Robert Kirkman (2 out of 2 patents)

10 Mark J Krantz (2 out of 3 patents)

11 Zi-Hua Jiang (2 out of 3 patents)

12 Zi-hua Jiang (1 out of 3 patents)

13 Damayanthi Yalamati (1 out of 3 patents)

14 Myung-Gi Baek (1 out of 1 patent)

15 Rao R Koganty (1 out of 3 patents)


10 patents:

Oncothyreon is a biotechnology company focused on the development of innovative oncology products for the treatment of cancer. With a pipeline of promising drug candidates and a team of experienced researchers, Oncothyreon is committed to advancing novel therapies that have the potential to improve patient outcomes and quality of life.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

10 Patents

#186 in Seattle, WA

#654 in Washington

#29,006 in US

#54,324 in the World

...
Seattle, WA, United States of America
Forward Citations = 58

15 inventors:

Please report any incorrect information to support@idiyas.com
Loading…